Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

Research output: Contribution to journal › Article › Academic › peer-review

14 Citations (Scopus)

26 Downloads (Pure)

Research programs

@article{31213a77a6294cc398fd21d5a2438e42,

title = "Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis",

author = "Matthijs Versteegh",

year = "2016",

doi = "10.1007/s40273-016-0421-0",

language = "Undefined/Unknown",

volume = "34",

pages = "1133--1144",

journal = "Pharmacoeconomics (Online)",

issn = "1179-2027",

publisher = "Adis",

}

TY - JOUR

T1 - Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

AU - Versteegh, Matthijs

PY - 2016

Y1 - 2016

U2 - 10.1007/s40273-016-0421-0

DO - 10.1007/s40273-016-0421-0

M3 - Article

C2 - 27282692

SN - 1179-2027

VL - 34

SP - 1133

EP - 1144

JO - Pharmacoeconomics (Online)

JF - Pharmacoeconomics (Online)

ER -